183 related articles for article (PubMed ID: 34323409)
21. MYH9 promotes cell metastasis
Yang B; Liu H; Bi Y; Cheng C; Li G; Kong P; Zhang L; Shi R; Zhang Y; Zhang R; Cheng X
Int J Med Sci; 2020; 17(13):2013-2023. PubMed ID: 32788880
[TBL] [Abstract][Full Text] [Related]
22. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R
Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327
[TBL] [Abstract][Full Text] [Related]
23. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
24. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
[TBL] [Abstract][Full Text] [Related]
25. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
26. Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.
West NR; Farnell B; Murray JI; Hof F; Watson PH; Boulanger MJ
Protein Sci; 2009 Dec; 18(12):2615-23. PubMed ID: 19844956
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway.
Sun Y; Qian Y; Chen C; Wang H; Zhou X; Zhai W; Qiu L; Zhou X; Ning H; Zhao Y; Shi C; Han L; Qi Y; Wu Y; Gao Y
J Exp Clin Cancer Res; 2022 Apr; 41(1):145. PubMed ID: 35428295
[TBL] [Abstract][Full Text] [Related]
28. Protocadherin 8 (PCDH8) Inhibits Proliferation, Migration, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma.
Yu H; Jiang X; Jiang L; Zhou H; Bao J; Zhu X; Liu F; Huang J
Med Sci Monit; 2020 Apr; 26():e920665. PubMed ID: 32330123
[TBL] [Abstract][Full Text] [Related]
29. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
Feng A; He L; Jiang J; Chu Y; Zhang Z; Fang K; Wang Z; Li Z; Sun M; Zhao Z; Shi J; Zhang L; Chen T; Xu M
Cancer Sci; 2023 Aug; 114(8):3270-3286. PubMed ID: 37248653
[TBL] [Abstract][Full Text] [Related]
30. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.
Mishra S; Charan M; Shukla RK; Agarwal P; Misri S; Verma AK; Ahirwar DK; Siddiqui J; Kaul K; Sahu N; Vyas K; Garg AA; Khan A; Miles WO; Song JW; Bhutani N; Ganju RK
J Exp Clin Cancer Res; 2022 Feb; 41(1):54. PubMed ID: 35135586
[TBL] [Abstract][Full Text] [Related]
31. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
33. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis.
Guo X; Meng X; Liu R
Pathol Res Pract; 2021 Nov; 227():153644. PubMed ID: 34634564
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
[TBL] [Abstract][Full Text] [Related]
36. PD_BiBIM: Biclustering-based biomarker identification in ESCC microarray data.
Patowary P; Bhattacharyya DK
J Biosci; 2021; 46():. PubMed ID: 34148879
[TBL] [Abstract][Full Text] [Related]
37. SPI1-Mediated Upregulation of the
Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J
Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920
[TBL] [Abstract][Full Text] [Related]
39. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
40. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
